Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;15(2):136-147.
doi: 10.1159/000506254. Epub 2020 Feb 21.

Accelerated Partial Breast Irradiation: A New Standard of Care?

Tobias Forster  1   2   3 , Clara Victoria Katharina Köhler  1 , Jürgen Debus  1   2   3   4   5   6 , Juliane Hörner-Rieber  1   2   3   4
Affiliations
Review

Accelerated Partial Breast Irradiation: A New Standard of Care?

Tobias Forster et al. Breast Care (Basel). 2020 Apr.

Abstract

Background: Breast-conserving therapy including lumpectomy and adjuvant whole breast irradiation (WBI) has become the standard therapy for early-stage breast cancer (EBC). Without WBI, the recurrence rate is significantly increased. However, when selecting patients at a low a priori risk of local recurrence only a small breast-cancer-specific mortality benefit, but no overall survival improvement, was detected for WBI. As most recurrences occur close to the lumpectomy cavity, accelerated partial breast irradiation (APBI) delivered exclusively to a limited volume of tissue around the initial lumpectomy site, has gained increased attention and is now discussed as an alternative to WBI for selected EBC patients.

Summary: Numerous techniques for APBI (interstitial brachytherapy, external beam-based APBI, intraoperative radiotherapy, MR-guided radiotherapy) allow treatment delivery in a shorter period of time, and radiation oncologists expect to further reduce side effects by using these new techniques, with improvements in cosmetics and quality of life. In this review, we aim to describe the existing evidence for the feasibility and effectiveness of different APBI techniques used in modern radiotherapy.

Key messages: APBI has provided outcomes similar to WBI combined with potentially reduced toxicity. While appropriate patient selection persists to be crucial for acceptable recurrence rates, the precise definition of patients suitable for APBI remains a matter of discussion. As long-term data are often still lacking, special attention should be paid to late side effects and long-term outcomes. Decision-making on appropriate treatment techniques should take into account not only local control rates, but also the impact on the patient's quality of life.

Keywords: Accelerated partial breast irradiation (APBI); Breast cancer; External beam-based APBI; Interstitial brachytherapy; Intraoperative radiotherapy; MR-guided radiotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Flowchart of the COSMOPOLITAN trial.
Fig. 2
Fig. 2
MR-guided APBI. A, B Treatment plan and dose-volume histogram of MR-guided APBI delivered at Heidelberg University with a total dose of 40.05 Gy in 15 fractions as second breast-conserving therapy due to local recurrence. The resection cavity is shown in orange, while the planning target volume is delineated in red. C–F MR real-time cine imaging with the target (resection cavity) within the specified gating margin (C) and the beam turned on (D) and >3% of the target located outside of the specified gating margin (E) and the beam turned off (F).
See this image and copyright information in PMC

References

    1. Marta GN, Hanna SA, Martella E, Silva JL, Carvalho Hde A. Early stage breast cancer and radiotherapy: update. Rev Assoc Med Bras (1992) 2011 Jul-Aug;57((4)):459–64. - PubMed
    1. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol. 2007 Jul;84((1)):84–101. - PubMed
    1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002 Oct;347((16)):1227–32. - PubMed
    1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002 Oct;347((16)):1233–41. - PubMed
    1. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;((11)):15–8. - PubMed